Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9198 | 1110 | 30.4 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
792 | 11459 | QUORUM SENSING//PSEUDOMONAS AERUGINOSA//QUORUM QUENCHING |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OE 6710 | Address | 15 | 82% | 1% | 9 |
2 | PYOCIN TYPING | Author keyword | 11 | 100% | 1% | 6 |
3 | KLIN FOR ERGRP | Address | 5 | 20% | 2% | 24 |
4 | NIHR BIOMED MICROBIAL DIS | Address | 3 | 50% | 0% | 5 |
5 | BACTERIAL PATHOGENS CYST FIBROSIS GRP | Address | 3 | 100% | 0% | 3 |
6 | TRANSFERABLE ANTIBIOTIC RESISTANCE | Author keyword | 3 | 100% | 0% | 3 |
7 | REG ADULT CYST FIBROSIS UNIT | Address | 3 | 20% | 1% | 12 |
8 | ARTIFICIAL SPUTUM MEDIUM | Author keyword | 2 | 67% | 0% | 2 |
9 | CLONAL STRAIN | Author keyword | 2 | 67% | 0% | 2 |
10 | DISCIPLINE IMMUNOL INFECT DIS | Address | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PYOCIN TYPING | 11 | 100% | 1% | 6 | Search PYOCIN+TYPING | Search PYOCIN+TYPING |
2 | TRANSFERABLE ANTIBIOTIC RESISTANCE | 3 | 100% | 0% | 3 | Search TRANSFERABLE+ANTIBIOTIC+RESISTANCE | Search TRANSFERABLE+ANTIBIOTIC+RESISTANCE |
3 | ARTIFICIAL SPUTUM MEDIUM | 2 | 67% | 0% | 2 | Search ARTIFICIAL+SPUTUM+MEDIUM | Search ARTIFICIAL+SPUTUM+MEDIUM |
4 | CLONAL STRAIN | 2 | 67% | 0% | 2 | Search CLONAL+STRAIN | Search CLONAL+STRAIN |
5 | CLONAL DIFFUSION | 1 | 100% | 0% | 2 | Search CLONAL+DIFFUSION | Search CLONAL+DIFFUSION |
6 | HEAD OUT SPIROMETRY | 1 | 100% | 0% | 2 | Search HEAD+OUT+SPIROMETRY | Search HEAD+OUT+SPIROMETRY |
7 | LIVERPOOL EPIDEMIC STRAIN | 1 | 100% | 0% | 2 | Search LIVERPOOL+EPIDEMIC+STRAIN | Search LIVERPOOL+EPIDEMIC+STRAIN |
8 | MULTIPLEX PRIMER EXTENSION ASSAY | 1 | 100% | 0% | 2 | Search MULTIPLEX+PRIMER+EXTENSION+ASSAY | Search MULTIPLEX+PRIMER+EXTENSION+ASSAY |
9 | PAPI 1 | 1 | 100% | 0% | 2 | Search PAPI+1 | Search PAPI+1 |
10 | TIME KILLING EXPERIMENTS | 1 | 100% | 0% | 2 | Search TIME+KILLING+EXPERIMENTS | Search TIME+KILLING+EXPERIMENTS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRANSMISSIBLE STRAINS | 15 | 71% | 1% | 12 |
2 | TRANSMISSIBLE STRAIN | 15 | 88% | 1% | 7 |
3 | GENETIC ADAPTATION | 9 | 22% | 3% | 35 |
4 | DISCRIMINATORY POWER | 7 | 26% | 2% | 23 |
5 | EPIDEMIC POPULATION STRUCTURE | 7 | 67% | 1% | 6 |
6 | HUMAN HOST ENVIRONMENT | 6 | 71% | 0% | 5 |
7 | CROSS INFECTION | 6 | 16% | 3% | 35 |
8 | CROSS COLONIZATION | 6 | 50% | 1% | 8 |
9 | INTENSIVE THERAPY UNIT | 5 | 63% | 0% | 5 |
10 | LASR MUTANTS | 5 | 33% | 1% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Association between healthcare water systems and Pseudomonas aeruginosa infections: a rapid systematic review | 2014 | 7 | 30 | 87% |
Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections | 2012 | 29 | 115 | 73% |
Pseudomonas aeruginosa: a formidable and ever-present adversary | 2009 | 118 | 38 | 53% |
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective | 2012 | 78 | 104 | 18% |
Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung | 2010 | 63 | 35 | 29% |
Pseudomonas aeruginosa outbreaks in the neonatal intensive care unit - a systematic review of risk factors and environmental sources | 2012 | 18 | 43 | 51% |
PCR and the detection of Pseudomonas aeruginosa in respiratory samples of CF patients. A literature review | 2011 | 19 | 21 | 57% |
Infection prevention and control in cystic fibrosis | 2011 | 20 | 15 | 53% |
Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis | 2010 | 14 | 81 | 51% |
Pseudomonas genomes: diverse and adaptable | 2011 | 102 | 205 | 14% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OE 6710 | 15 | 82% | 0.8% | 9 |
2 | KLIN FOR ERGRP | 5 | 20% | 2.2% | 24 |
3 | NIHR BIOMED MICROBIAL DIS | 3 | 50% | 0.5% | 5 |
4 | BACTERIAL PATHOGENS CYST FIBROSIS GRP | 3 | 100% | 0.3% | 3 |
5 | REG ADULT CYST FIBROSIS UNIT | 3 | 20% | 1.1% | 12 |
6 | DISCIPLINE IMMUNOL INFECT DIS | 2 | 67% | 0.2% | 2 |
7 | GRP CLONAL VARIABIL | 2 | 50% | 0.3% | 3 |
8 | SEQUENOM ASIA PACIFIC | 1 | 50% | 0.2% | 2 |
9 | W MIDLANDS ADULT CF UNIT | 1 | 50% | 0.2% | 2 |
10 | GRP BACTERIAL OPPORTUNIST PATHOGENS ENVIRON | 1 | 18% | 0.5% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000182304 | METALLO BETA LACTAMASE//METALLO BETA LACTAMASES//VIM 2 |
2 | 0.0000151266 | EXOU//EXOENZYME S//PSEUDOMONAL ELASTASE |
3 | 0.0000126785 | BURKHOLDERIA CEPACIA COMPLEX//BURKHOLDERIA CEPACIA//BURKHOLDERIA CENOCEPACIA |
4 | 0.0000123724 | RD BIOSCI//PSEUDOMONAS VACCINE//PNEUMONIA CLIN |
5 | 0.0000119477 | JOURNAL OF CYSTIC FIBROSIS//INHALED TOBRAMYCIN//PULMONARY EXACERBATION |
6 | 0.0000111959 | SAHMRI INFECT IMMUN THEME//CYST FIBROSIS UNIT//OROPHARYNGEAL FLORA |
7 | 0.0000111905 | ECTHYMA GANGRENOSUM//PSEUDOMONAS SEPSIS//1 BROMO 3 CHLORO 5 5 DIMETHYLHYDANTOIN |
8 | 0.0000075085 | MED INVEST LIM 54//PSEUDOFUNGEMIA//PSEUDOINFECTION |
9 | 0.0000072842 | COLD MICROBIOL//BACTERIAL HEMORRHAGIC ASCITES//FLAVIMONAS ORYZIHABITANS |
10 | 0.0000071526 | CYSTIC FIBROSIS PARANASAL SINUSES//NASAL POLYPS COMPLICATIONS DRUG THERAPY//SINUS DEVELOPMENT |